257 related articles for article (PubMed ID: 21317614)
1. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.
Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B
Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614
[TBL] [Abstract][Full Text] [Related]
2. The dermal stem cell factor and c-kit are overexpressed in melasma.
Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
[TBL] [Abstract][Full Text] [Related]
3. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing.
Huttunen M; Naukkarinen A; Horsmanheimo M; Harvima IT
Arch Dermatol Res; 2002 Oct; 294(7):324-30. PubMed ID: 12373338
[TBL] [Abstract][Full Text] [Related]
4. Does altered basement membrane of melasma lesion affect treatment outcome in Asian skin?
Choi JR; Won CH; Oh ES; An J; Chang SE
Am J Dermatopathol; 2013 Feb; 35(1):137-8. PubMed ID: 23348143
[No Abstract] [Full Text] [Related]
5. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
[TBL] [Abstract][Full Text] [Related]
6. The histopathological characteristics of male melasma: comparison with female melasma and lentigo.
Jang YH; Sim JH; Kang HY; Kim YC; Lee ES
J Am Acad Dermatol; 2012 Apr; 66(4):642-9. PubMed ID: 22285674
[TBL] [Abstract][Full Text] [Related]
7. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy.
Riekki R; Harvima IT; Jukkola A; Risteli J; Oikarinen A
Exp Dermatol; 2004 Jun; 13(6):364-71. PubMed ID: 15186323
[TBL] [Abstract][Full Text] [Related]
8. Melasma: histopathological characteristics in 56 Korean patients.
Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Pathology of Melasma and Its Clinical Implications.
Kwon SH; Hwang YJ; Lee SK; Park KC
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341
[TBL] [Abstract][Full Text] [Related]
10. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema.
Järvikallio A; Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.
Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758
[TBL] [Abstract][Full Text] [Related]
13. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.
Miot LD; Miot HA; Polettini J; Silva MG; Marques ME
Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990
[TBL] [Abstract][Full Text] [Related]
14. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of SCF in the dermis is a prognostic factor for the regression of urticaria pigmentosa.
Onuma H; Matsui C; Morokashi M
Eur J Dermatol; 1999 Dec; 9(8):629-32. PubMed ID: 10586131
[TBL] [Abstract][Full Text] [Related]
16. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.
Norris A; Todd C; Graham A; Quinn AG; Thody AJ
Br J Dermatol; 1996 Feb; 134(2):299-306. PubMed ID: 8746346
[TBL] [Abstract][Full Text] [Related]
17. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
[TBL] [Abstract][Full Text] [Related]
18. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma.
Bak H; Lee HJ; Chang SE; Choi JH; Kim MN; Kim BJ
Dermatol Surg; 2009 Aug; 35(8):1244-50. PubMed ID: 19438666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
